S100A4 and Hepatic fibrosis: Moreover, PRI-724 treatment reduced liver fibrosis and S100a4 expression without affecting serum alanine aminotransferase (ALT) levels, suggesting that the antifibrotic effects of PRI-724 are not due to the reduction of hepatocellular damage.